GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » PharmX Technologies Ltd (ASX:PHX) » Definitions » Cyclically Adjusted PS Ratio

PharmX Technologies (ASX:PHX) Cyclically Adjusted PS Ratio : 0.60 (As of Jun. 06, 2024)


View and export this data going back to 1973. Start your Free Trial

What is PharmX Technologies Cyclically Adjusted PS Ratio?

As of today (2024-06-06), PharmX Technologies's current share price is A$0.03. PharmX Technologies's Cyclically Adjusted Revenue per Share for the fiscal year that ended in Jun23 was A$0.05. PharmX Technologies's Cyclically Adjusted PS Ratio for today is 0.60.

The historical rank and industry rank for PharmX Technologies's Cyclically Adjusted PS Ratio or its related term are showing as below:

ASX:PHX' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 0.2   Med: 0.67   Max: 1.67
Current: 0.57

During the past 13 years, PharmX Technologies's highest Cyclically Adjusted PS Ratio was 1.67. The lowest was 0.20. And the median was 0.67.

ASX:PHX's Cyclically Adjusted PS Ratio is ranked better than
71.14% of 343 companies
in the Healthcare Providers & Services industry
Industry Median: 1.23 vs ASX:PHX: 0.57

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

PharmX Technologies's adjusted revenue per share data of for the fiscal year that ended in Jun23 was A$0.010. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is A$0.05 for the trailing ten years ended in Jun23.

Shiller PE for Stocks: The True Measure of Stock Valuation


PharmX Technologies Cyclically Adjusted PS Ratio Historical Data

The historical data trend for PharmX Technologies's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PharmX Technologies Cyclically Adjusted PS Ratio Chart

PharmX Technologies Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.42 0.64 1.51 0.64 0.78

PharmX Technologies Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 0.64 - 0.78 -

Competitive Comparison of PharmX Technologies's Cyclically Adjusted PS Ratio

For the Health Information Services subindustry, PharmX Technologies's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PharmX Technologies's Cyclically Adjusted PS Ratio Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, PharmX Technologies's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where PharmX Technologies's Cyclically Adjusted PS Ratio falls into.



PharmX Technologies Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

PharmX Technologies's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=0.03/0.05
=0.60

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PharmX Technologies's Cyclically Adjusted Revenue per Share for the fiscal year that ended in Jun23 is calculated as:

For example, PharmX Technologies's adjusted Revenue per Share data for the fiscal year that ended in Jun23 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Jun23 (Change)*Current CPI (Jun23)
=0.01/124.1700*124.1700
=0.010

Current CPI (Jun23) = 124.1700.

PharmX Technologies Annual Data

Revenue per Share CPI Adj_RevenuePerShare
201406 0.067 98.352 0.085
201506 0.062 99.838 0.077
201606 0.058 100.859 0.071
201706 0.050 102.809 0.060
201806 0.041 104.945 0.049
201906 0.038 106.617 0.044
202006 0.025 106.246 0.029
202106 0.023 110.332 0.026
202206 0.020 117.112 0.021
202306 0.010 124.170 0.010

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


PharmX Technologies  (ASX:PHX) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


PharmX Technologies Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of PharmX Technologies's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


PharmX Technologies (ASX:PHX) Business Description

Traded in Other Exchanges
N/A
Address
17 Castlereagh Street, Level 11, Sydney, NSW, AUS, 2000
PharmX Technologies Ltd Formerly Corum Group Ltd is an Australia-based software and technology company. The company has a single segment which is Health Services. In Health services, the company develops and distributes business software for the pharmacy industry with particular emphasis on point-of-sale and pharmaceutical dispensing software, support services, and associated computer hardware. It derives a majority of its revenue from the Health services business. the company discontinued the e-commerce business in 2022.